Showing results (131-140 of 1,109) with videos related to
Sort By:
Pageof 111
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Lowering the risk of Alzheimer's disease: evidence-based practices emerge from new researchM Kathryn Jedrziewski, Virginia M-Y Lee, John Q TrojanowskiGlia|June 20, 1998
Lesion-induced changes in the expression of ciliary neurotrophic factor and its receptor in rat optic nerveM Kirsch, T Schneider, M Y Lee, et al.Trends in Neurosciences|March 24, 2004
More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseasesVirginia M-Y Lee, Benoit I Giasson, John Q TrojanowskiNeuron|August 17, 2005
Nosology of Parkinson's disease: looking for the way out of a quagmireMark S Forman, Virginia M-Y Lee, John Q TrojanowskiNeuromolecular Medicine|October 7, 2003
Interactions of amyloidogenic proteinsBenoit I Giasson, Virginia M-Y Lee, John Q TrojanowskiHong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 19, 2013
Role of cyclooxygenase-2 in H5N1 viral pathogenesis and the potential use of its inhibitorsM Y Lee, C Y Cheung, J S M PeirisJournal of Neuroscience Research|November 5, 2003
Distinct presenilin-dependent and presenilin-independent gamma-secretases are responsible for total cellular Abeta productionChristina A Wilson, Robert W Doms, Virginia M-Y LeeAnnual Review of Pathology|November 28, 2007
Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implicationsDaniel M Skovronsky, Virginia M-Y Lee, John Q TrojanowskiNature Reviews. Drug Discovery|October 2, 2009
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathiesKurt R Brunden, John Q Trojanowski, Virginia M-Y LeeTrends in Molecular Medicine|July 26, 2011
TDP-43 functions and pathogenic mechanisms implicated in TDP-43 proteinopathiesTodd J Cohen, Virginia M Y Lee, John Q TrojanowskiPageof 111